The War on Pot Is an Abject Failure ... Now's the Time for a New Approach
Also in DrugReporter
The Feds Are Addicted to Pot -- Even If You Aren't
Paul Armentano
A Smart Way to Battle Drug Addiction and Save Lives: Harm Reduction
Melinda Tuhus
The War on Weed: Marijuana Is Basically Harmless -- The Monumentally Stupid Drug War Is Not
Jim Hightower
When It’s Crunch Time at College, Students Turn to Adderall
Erik Hayden
In Historic Shift, the American Medical Association Sees Value in Marijuana
Phillip S. Smith
The Relentless War on Drug Users Is Escalating Violence in the US: It's Time for Harm Reduction
Don Hazen
Practically overnight, faster than you can say "Depression 2.0", a ballooning number of politicians, mainstream media journalists, and members of the public are acknowledging the fact that cannabis prohibition isn't drug control — it's drug chaos.
In the U.S. -- where 42 percent of the adult population has used cannabis -- three-quarters of a million citizens are arrested every year for simple possession, draining limited resources from pressing issues like education, health care, and real "criminal justice". South of the border, where cannabis comprises more than half of Mexico's drug trafficking market, prohibitionist policies are fueling a grim and growing war that recently prompted the U.S. Joint Forces Command to warn that Mexico is in danger of becoming a failed state.
No wonder three-quarters of U.S. citizens think that the drug war is a failure, several states have introduced legislation this year to implement or expand decriminalization, and public support for outright marijuana legalization is polling higher than ever. Meanwhile, the crumbling economy has highlighted the monumental costs of cannabis enforcement, prosecution, and incarceration, not to mention the billions in potential taxes conceded to organized crime. (In a 2006 report, expert Jon Gettman used conservative estimates to value the annual U.S. cannabis crop at $36 billion -- absurdly, more than corn and wheat combined.)
Abroad, the international community is also acknowledging the futility of U.S.-style prohibition as a model for global drug policy, and several countries have turned toward health-based approaches more in line with the U.N.’s health and human rights mandates. Cannabis is subject to international control by the 1961 Single Convention on Narcotic Drugs, as amended in 1971, and it is also affected by the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. Although signatories of the international drug control treaties are formally required to criminalize the production, distribution, sale, use and possession of cannabis, a number of countries -- such as the Netherlands, Brazil, Germany, Italy, Belgium, Spain, Switzerland, Denmark, Portugal, Austria and India -- have adopted less punitive policies.
Yet, while the political viability of cannabis reform is reaching new found heights, there is a noticeable lack of consensus about the specific systems of regulation that could replace the current model.
Moving Beyond Stalemate
Enter the Global Cannabis Commission, an international team of leading public health policy experts (including Peter Reuter, Senior Economist at RAND) convened by the UK's Beckley Foundation. The Commission's Report and Draft Framework Convention on Cannabis Control map out solutions to break the current international stalemate, forming a blueprint for nations seeking to develop a more humane and effective approach to the control of cannabis. Among its recommendations, the Commission suggests reforming the international conventions to allow countries the leeway to implement differing systems of regulation that best suit their individual needs, even to the point of state production and licensed sale. The Commission identifies and analyzes potential routes forward -- depenalization, decriminalization, partial legality, and, finally, a regulated legal market.
See more stories tagged with: marijuana prohibition
Jag Davies is U.S. public policy coordinator at theBeckley Foundation.
Liked this story? Get top stories in your inbox each week from DrugReporter! Sign up now »
You've chosen to turn comments off for the entire site. Would you like to turn them back on?
Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.